BEST-CLI 试验中因肢体威胁性缺血行旁路或血管内血运重建后心血管严重不良事件的特征分析
BEST-CLI 前瞻性随机试验比较了慢性肢体威胁性缺血患者开放手术(OPEN)与血管内(ENDO)血运重建后30天心脏及血管严重不良事件(SAE)。OPEN 组850例、ENDO 组896例干预中,心脏 SAE 发生率分别为4.7%与3.8%(P=0.35),血管 SAE 分别为6.8%与9.6%(P=0.19),两组严重程度及与手术相关比例相似。
要点
- OPEN 与 ENDO 血运重建后30天心脏 SAE 发生率分别为4.7%与3.8%,差异无统计学意义(P=0.35)。
- OPEN 与 ENDO 后血管 SAE 发生率分别为6.8%与9.6%,差异无统计学意义(P=0.19)。
- 两组约半数 SAE 为严重,多数 SAE 与索引干预无关。
核心结论
- 接受 OPEN 与 ENDO 血运重建的患者心脏及血管 SAE 程度相似,多数与索引干预无关,但约半数为严重。
研究设计与样本
- BEST-CLI 为前瞻性随机试验,比较慢性肢体威胁性缺血患者开放手术(OPEN)与血管内(ENDO)血运重建,按方案分析30天心脏及血管 SAE。
- 共评估850例 OPEN 干预和896例 ENDO 干预。
主要发现
- OPEN 组40例(4.7%)与 ENDO 组34例(3.8%)患者发生至少一次心脏 SAE(P=0.35)。
- OPEN 组共53次心脏 SAE(每例0.06次),ENDO 组共40次(每例0.045次)。
- OPEN 组心脏 SAE 分类为缺血50.9%、心律失常17%、心力衰竭15.1%、心脏骤停13.2%、心脏传导阻滞3.8%;ENDO 组为缺血47.5%、心力衰竭17.5%、心律失常15%、心脏骤停15%、心脏传导阻滞5%。
- OPEN 组心脏 SAE 明确或可能与手术相关者为30.2%,ENDO 组为25%(P=0.2);两组约半数心脏 SAE 为严重。
- OPEN 组58例(6.8%)与 ENDO 组86例(9.6%)患者发生血管 SAE(P=0.19);OPEN 组共59次(每例0.07次),ENDO 组共87次(每例0.097次)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cardiovascular complications after revascularization to treat chronic limb-threatening ischemia (CLTI) are a major concern that guides treatment. Our goal was to assess periprocedural cardiac and vascular serious adverse events (SAEs) in the Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial. METHODS: BEST-CLI was a prospective randomized trial comparing surgical (OPEN) and endovascular (ENDO) revascularization for patients with CLTI. Thirty-day SAEs, classified as cardiac or vascular, were analyzed. Adverse events are defined as serious when they affect safety in the trial, require prolonged hospitalization, result in significant disability or incapacitation, are life-threatening, or result in death. Interventions were analyzed in a per protocol fashion. RESULTS: In the BEST-CLI trial, 850 OPEN and 896 ENDO interventions were evaluated. Forty (4.7%) and 34 (3.8%) patients experienced at least one cardiac SAE after OPEN and ENDO intervention, respectively (P = .35). Overall, there were 53 cardiac SAEs (0.06 per patient) after OPEN and 40 (0.045 per patient) after ENDO interventions. Cardiac SAEs in the OPEN arm were classified as related to ischemia (50.9%), arrhythmias (17%), heart failure (15.1%), arrest (13.2%), and heart block (3.8%); in the ENDO arm, they were classified as ischemia (47.5%), heart failure (17.5%), arrhythmias (15%), arrest (15%), and heart block (5%). Approximately half of SAEs were classified as severe for both OPEN and ENDO. SAEs were definitely or probably related to the procedure in 30.2% and 25% in the OPEN and ENDO arms, respectively (P = .2). Vascular SAEs occurred in 58 (6.8%) and 86 (9.6%) of patients after OPEN and ENDO revascularization, respectively (P = .19). In total, there were 59 (0.07 per patient) and 87 (0.097 per patient) vascular SAEs after OPEN and ENDO procedures. Vascular SAEs in the OPEN arm were classified as distal ischemia/infection (44.1%), bleeding (16.9%), occlusive (15.3%), thromboembolic (15.3%), cerebrovascular (5.1%), and other (3.4%); in the ENDO arm, they were distal ischemia/infection (40.2%), occlusive (31%), bleeding (12.6%), thromboembolic (8%), cerebrovascular (1.1%), and other (4.6%). SAEs were classified as severe for OPEN in 45.8% and ENDO in 46%. SAEs were definitely or probably related to the procedure in 23.7% and 35.6% in the OPEN and ENDO arms (P = .35), respectively. CONCLUSIONS: Patients undergoing OPEN and ENDO revascularization experienced similar degrees of cardiac and vascular SAEs. The majority were not related to the index intervention, but approximately half were severe.
引用
- Siracuse JJ, Menard MT, Rosenfield K, et al. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial. J Vasc Surg. 2024. PMID: 38626847. doi:10.1016/j.jvs.2024.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。